Journal Name: Journal of the National Cancer Institute
Journal Type: Q1
ISSN: 00278874, 14602105
Country: United Kingdom
Subject Area and Category: Biochemistry, Genetics and Molecular Biology Cancer Research Medicine Oncology
Publisher: Oxford University Press
Research Ranking: 22
Publication Type: Journals
H-Index: 394
Coverage: 1940-2025
Editors-in-Chief: Dr. Eduardo L. Franco
Research Impact Score: 44.9
Impact Factor: 11.816
SCIMAGO SJR: 5.703
APC Cost: $5177.12
Homepage: http://jnci.oxfordjournals.org/
Submission Link: https://academic.oup.com/jnci
Contact Email: JNCI.edoffice@oup.com
Address: 407 St John Street, London, EC1V 4AD, UK.
Overview
The Journal of the National Cancer Institute (JNCI) is a premier peer-reviewed journal recognized globally for publishing groundbreaking cancer research. Established in 1940, JNCI has remained at the forefront of oncology, providing invaluable insights into cancer prevention, diagnosis, treatment, and policy. With its long-standing reputation and commitment to high-impact studies, the journal continues to shape the future of cancer research and patient care.
Mission and Scope
JNCI's primary mission is to disseminate high-quality, evidence-based research that advances our understanding of cancer and improves public health outcomes. The journal welcomes original research articles, reviews, commentaries, and editorials that address a wide range of cancer-related topics. Key focus areas include cancer epidemiology, molecular biology, clinical trials, translational research, cancer prevention, and health disparities.
High-Impact Research and Global Reach
One of the key strengths of JNCI lies in its rigorous peer-review process and editorial standards. This ensures that only the most robust and innovative studies are published. The journal is known for publishing large-scale clinical trials, population-based studies, and translational research that bridges the gap between laboratory science and clinical application.
As a high-impact journal, JNCI’s articles are widely cited and influential across the global scientific community. Researchers, clinicians, public health professionals, and policymakers turn to JNCI for authoritative insights and updates on cancer trends, novel treatments, and public health strategies.
Notable Features and Sections
JNCI regularly features special issues and supplements that spotlight emerging topics in oncology, such as precision medicine, immunotherapy, and cancer genomics. In addition, the journal includes:
-
Editorials and Commentaries: Offering expert perspectives on current research and policy issues.
-
Review Articles: Summarizing recent advances in specific areas of cancer research.
-
Brief Communications: Highlighting novel findings with significant implications for future research.
Accessibility and Online Presence
To ensure broad accessibility, JNCI is available online through Oxford University Press, offering a user-friendly platform for researchers and readers. Many articles are open access, supporting the global exchange of scientific knowledge. The journal also maintains an active presence on social media platforms, disseminating key research findings and updates to a broader audience.
Why JNCI Matters in the Fight Against Cancer
The Journal of the National Cancer Institute plays a vital role in advancing oncology research and guiding evidence-based practice. By fostering collaboration across scientific disciplines and geographic boundaries, JNCI contributes significantly to reducing the global burden of cancer. Its commitment to excellence, innovation, and impact makes it a trusted source for the latest developments in cancer science.
About
The Journal of the National Cancer Institute (JNCI) stands as one of the most authoritative and widely respected peer-reviewed publications in the field of oncology. Published by Oxford University Press, JNCI serves as an essential resource for cancer researchers, clinicians, and healthcare professionals worldwide who are committed to advancing the understanding, diagnosis, treatment, and prevention of cancer.
What is the Journal of the National Cancer Institute?
Founded in 1940, the Journal of the National Cancer Institute has a long and distinguished history of publishing cutting-edge cancer research. It is the official journal of the National Cancer Institute (NCI), a part of the U.S. National Institutes of Health (NIH). The journal focuses on publishing high-impact original research articles, reviews, editorials, and commentary on all aspects of cancer research, including molecular biology, epidemiology, clinical trials, prevention, and survivorship.
Impact Factor and Reputation
JNCI is consistently ranked among the top journals in oncology. It boasts a high impact factor, reflecting the significance and influence of its published research. The journal’s rigorous peer-review process ensures the quality and reliability of the content, making it a trusted source for oncologists, researchers, and policy-makers globally.
Key Areas of Focus
The Journal of the National Cancer Institute covers a broad spectrum of topics, including but not limited to:
-
Cancer biology and genetics
-
Clinical oncology and therapeutic developments
-
Cancer prevention and early detection
-
Epidemiology and public health
-
Health disparities and survivorship
-
Translational research
By addressing both clinical and basic science perspectives, JNCI plays a critical role in bridging the gap between laboratory research and patient care.
Accessibility and Reach
JNCI offers open access options to ensure that groundbreaking research reaches the widest possible audience. Researchers and practitioners around the world rely on JNCI for the latest updates in cancer research and clinical practice guidelines. The journal is indexed in leading medical databases, including PubMed, Scopus, and Web of Science, enhancing its visibility and accessibility.
Why Choose JNCI?
For researchers looking to publish high-quality cancer research, JNCI offers:
-
Rigorous peer review
-
Wide international readership
-
High citation rates
-
Professional editorial support
-
Rapid publication timelines
The journal's commitment to excellence has earned it a prestigious place in the scientific community, making it a first choice for authors and a must-read for healthcare professionals.
Scope
The Journal of the National Cancer Institute (JNCI) is one of the most prestigious and widely recognized journals in the field of oncology. As a leading peer-reviewed publication, JNCI plays a critical role in disseminating cutting-edge cancer research, fostering innovation, and informing clinical practice worldwide. With a strong commitment to scientific excellence and public health, the journal serves as a cornerstone for oncologists, researchers, and healthcare professionals seeking to stay at the forefront of cancer science.
Comprehensive Coverage of Cancer Research
The scope of the Journal of the National Cancer Institute encompasses a broad spectrum of topics across basic, translational, and clinical cancer research. It publishes high-impact studies that explore the biology, prevention, diagnosis, and treatment of cancer. This includes original research articles, reviews, and editorials that address molecular oncology, cancer genomics, tumor immunology, epidemiology, and public health implications.
Key areas of focus include:
-
Cancer Biology and Genetics: Studies on tumor progression, metastasis, oncogenes, tumor suppressors, and cellular pathways.
-
Translational Research: Research that bridges laboratory discoveries with clinical applications.
-
Clinical Trials: Phase I–III trials evaluating new therapies, treatment combinations, and patient outcomes.
-
Cancer Prevention and Screening: Strategies for early detection and risk reduction.
-
Survivorship and Quality of Life: Research on the long-term effects of cancer and its treatment.
A Global Platform for Oncological Insights
JNCI attracts contributions from leading cancer centers, academic institutions, and research consortia around the world. Its international authorship and readership reflect its role as a global platform for oncology research. The journal encourages submissions that are interdisciplinary in nature and that offer novel insights with significant implications for cancer care and policy.
Emphasis on Evidence-Based Practice
Another core aspect of the journal’s scope is its emphasis on evidence-based clinical practice. By publishing systematic reviews, meta-analyses, and expert commentaries, JNCI supports informed decision-making in oncology. The journal aims to bridge the gap between research and practice, enabling clinicians to apply the latest evidence to improve patient care and outcomes.
Commitment to Scientific Integrity
JNCI is known for its rigorous peer-review process and high editorial standards. It prioritizes transparency, reproducibility, and ethical research conduct. This commitment ensures that every article published meets the highest standards of scientific validity and relevance.